This is the authors' abstract. We don't add key points for this paper.
Organic sonosensitizers, rationally engineered through band-gap and spin–orbit coupling control, convert ultrasound into cytotoxic ROS for sonodynamic cancer therapy. This review traces the path from molecular design to clinical translation.
No takes yet. Share an insight, caveat, or question.
Baig et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: